
-
2009
Company Description
Tarsa Therapeutics develops an oral formulation of calcitonin for the treatment and prevention of postmenopausal osteoporosis.
Tarsa Therapeutics is developing an oral formulation of calcitonin, a peptide hormone for the treatment of osteoporosis that slows the rate of bone destruction.
-
Manufacturer:
Science and Engineering -
Formed:
2009 -
Company Website:
-
Company E-mail:
-
Company Address:
8 Penn Center, 1628 John F. Kennedy Boulevard, Suite 1400Philadelphia, PAUnited States -
CEO:
- George R. Maurer
-
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits